Concepedia

Dalal Jadayel

DJ

9

Publications

1.3K

Citations

9

H-Index

1998

Active since

Affiliations

Institute of Cancer Research(Current)

Novartis (United States)

Novartis (United Kingdom)

University College London

Dalal Jadayel is an author at Institute of Cancer Research specializing in pathology, medicine, and cancer research.

Top concepts

Publications per year

1998–2014

9

Publications

9

Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types

Tony G. Willis, Dalal Jadayel, Ming‐Qing Du et al. · Cell · 1999 · 664 citations · Full text

, , +7

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors

Kim Appleton, Helen Mackay, Ian Judson et al. · Journal of Clinical Oncology · 2007 · 228 citations · Full text

A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Debashis Sarker, R. Molife, T. R. J. Evans et al. · Clinical Cancer Research · 2008 · 137 citations · Full text

Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study

Kai-Michael Beeh, Stephanie Korn, Jutta Beier et al. · Respiratory Medicine · 2014 · 107 citations · Full text

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study

Ronald Dahl, Dalal Jadayel, Vijay K. T. Alagappan et al. · International Journal of COPD · 2013 · 73 citations · Full text

Rows per page

1–5 of 9